A Phase 1/2 study of the safety, tolorability and efficacy of INCB24360 administered in combination with Nivolumab in select advanced cancers.
Clinical Trial Grant
Awarded By
Incyte Corporation
Start Date
April 1, 2015
End Date
March 30, 2020
Awarded By
Incyte Corporation
Start Date
April 1, 2015
End Date
March 30, 2020